As research continues to evolve, peptide therapy remains an exciting area of regenerative medicine for individuals seeking to support recovery, reduce inflammation, and improve overall wellness
Made by Eli Lilly the same company developing retatrutide
Retatrutide has progressed through Phase 2 clinical trials and into the Phase 3 TRIUMPH programme one of the most significant and closely watched clinical development programmes in metabolic research
Pharmacies making or distributing compounded GLP-1s use active pharmaceutical ingredients (APIs) that often are not evaluated or inspected by the FDA
Most people who experience side effects find them manageable, but a few may need to stop the medication if symptoms do not go away
The Promise and Responsibility of Peptide Therapy Peptides are an exciting frontier in bespoke modern medicine offering targeted, biologically intelligent support for metabolism, repair, energy, and longevity